⌘K

Home/Filings/4/0001104659-22-065285

4//SEC Filing

Zhou Quan 4

Accession 0001104659-22-065285

CIK 0000895051other

View on SEC.gov Company Profile

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:24 PM ET

Size

8.4 KB

Accession

0001104659-22-065285

Insider Transaction Report

Form 4

Period: 2022-05-25

CASI Pharmaceuticals, Inc.CASI

Director10% Owner

Transactions

Award
Stock Option (Right to Buy)
2022-05-25+380,645→ 380,645 total
Exercise: $0.47Exp: 2032-05-25→ Common Stock (380,645 underlying)

Footnotes (1)

[F1]Stock option award will vest ratably quarterly to the end of the year.

Documents

2 files

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1

filerCIK 0001491503

Filing Metadata

Form type: 4
Filed: May 25, 8:00 PM ET
Accepted: May 26, 4:24 PM ET
Size: 8.4 KB

View on SEC.gov